213 filings
Page 6 of 11
8-K
v2mv3ytoam
17 Sep 20
Regulation FD Disclosure
7:30am
8-K
lkewkgge7de
6 Aug 20
Kala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:05am
8-K
q1u0g2fk
26 Jun 20
Departure of Directors or Certain Officers
4:05pm
S-8
8842yjuxhhl4
25 Jun 20
Registration of securities for employees
4:06pm
DEFA14A
1918g2 f3qzprlglbnl
10 Jun 20
Additional proxy soliciting materials
8:10am
8-K
e2hyz 8dj6d
26 May 20
Other Events
8:05am
EFFECT
3hi4e1e
20 May 20
Notice of effectiveness
12:15am
CORRESP
6rq3r20ptrjlkmfst
15 May 20
Correspondence with SEC
12:00am
UPLOAD
snyrpb bxvrk5cjf82ly
13 May 20
Letter from SEC
12:00am
8-K
ts0o6isev772s8u
7 May 20
Kala Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
7:05am
CT ORDER
jcgnks8fnfy7
1 May 20
Confidential treatment order
12:00am
DEFA14A
qmhfh0sffwtjo38
29 Apr 20
Additional proxy soliciting materials
8:54am
8-K
ikvhyy 9mb
8 Apr 20
Regulation FD Disclosure
7:30am
8-K
wx8qfkhdhh
12 Mar 20
Kala Pharmaceuticals Announces Pricing of Public Offering of 16,000,000 Shares of Common Stock
12:00am
424B5
69f dzkgtyd7zoaxa
12 Mar 20
Prospectus supplement for primary offering
12:00am
8-K
vqd2hqafamxtk1p nup
11 Mar 20
Other Events
12:00am